Outsourcing: Analysis and developments of contract service providers to the pharmaceutical and biotechnology industries - Pharmaceutical Technology

ADVERTISEMENT



almanac button

submit article ideas here

ADVERTISEMENT

PharmTech Poll
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
30%
Breakthrough designations
10%
Protecting the supply chain
40%
Expedited reviews of drug submissions
10%
More stakeholder involvement
10%
View Results
pharmtech's list of regulatory databases
Foss

Content Uniformity Made Easy

Metrics

Custom Engineered Potent Products Facility

ADVERTISEMENT

Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Last updated on Thu Jul 24 16:08:33 EDT 2014

What is Quality by Design (QbD) – and Why Should You Care?
February 26, 2014
Charles - Genetic Assessment of Microbial Diversity in Four Geographically Separated Manufacturing Facilities in the United States
August 7, 2013
Preparing for Mandatory Electronic Submission of Drug Establishment Registration and Drug Listing Information
August 1, 2010
Outsourcing: A Rapid, Cost-Effective Option for Electronic Submissions
August 1, 2010
Advertiser Gallery
Click here